182 related articles for article (PubMed ID: 36196052)
1. Strategies for the enhancement of nail plate permeation of drugs to treat onychomycosis.
Gupta AK; Polla Ravi S; Choi SY; Konda A; Cooper EA
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):243-255. PubMed ID: 36196052
[TBL] [Abstract][Full Text] [Related]
2. Drug delivery to the nail: therapeutic options and challenges for onychomycosis.
Barot BS; Parejiya PB; Patel HK; Mehta DM; Shelat PK
Crit Rev Ther Drug Carrier Syst; 2014; 31(6):459-94. PubMed ID: 25271773
[TBL] [Abstract][Full Text] [Related]
3. Onychomycosis: Current Understanding and Strategies for Enhancing Drug Delivery into Human Nail Tissue.
Aslam R; Hussain T; Yousaf AM; Ghori MU; Khan IU; Rizvi SAA; Shahzad Y
Curr Drug Res Rev; 2021; 13(1):25-35. PubMed ID: 32735534
[TBL] [Abstract][Full Text] [Related]
4. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
Elsayed MM
J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
[TBL] [Abstract][Full Text] [Related]
5. Contemporary Techniques and Potential Transungual Drug Delivery Nanosystems for The Treatment of Onychomycosis.
Abd-Elsalam WH; Abouelatta SM
AAPS PharmSciTech; 2023 Jul; 24(6):150. PubMed ID: 37421509
[TBL] [Abstract][Full Text] [Related]
6. An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
McAuley WJ; Jones SA; Traynor MJ; Guesné S; Murdan S; Brown MB
Eur J Pharm Biopharm; 2016 May; 102():178-84. PubMed ID: 26969264
[TBL] [Abstract][Full Text] [Related]
7. Chemical and physical strategies in onychomycosis topical treatment: A review.
Angelo T; Borgheti-Cardoso LN; Gelfuso GM; Taveira SF; Gratieri T
Med Mycol; 2017 Jul; 55(5):461-475. PubMed ID: 27703019
[TBL] [Abstract][Full Text] [Related]
8. Treatment and management strategies of onychomycosis.
Aggarwal R; Targhotra M; Kumar B; Sahoo PK; Chauhan MK
J Mycol Med; 2020 Jun; 30(2):100949. PubMed ID: 32234349
[TBL] [Abstract][Full Text] [Related]
9. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
Bhatt V; Pillai R
J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
[TBL] [Abstract][Full Text] [Related]
10. The Penetrance of Topical Nail Therapy: Limitations and Current Enhancements.
Phan K; Kaur K; Wright K; Tran S; Stewart B; Brown M; Vlahovic TC
Clin Podiatr Med Surg; 2021 Oct; 38(4):535-540. PubMed ID: 34538431
[TBL] [Abstract][Full Text] [Related]
11. Insights into drug delivery across the nail plate barrier.
Saner MV; Kulkarni AD; Pardeshi CV
J Drug Target; 2014 Nov; 22(9):769-89. PubMed ID: 24964054
[TBL] [Abstract][Full Text] [Related]
12. Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis.
Pal P; Thakur RS; Ray S; Mazumder B
Drug Dev Ind Pharm; 2015; 41(7):1095-9. PubMed ID: 24980914
[TBL] [Abstract][Full Text] [Related]
13. Use of in vitro performance models in the assessment of drug delivery across the human nail for nail disorders.
Brown M; Turner R; Wevrett SR
Expert Opin Drug Deliv; 2018 Oct; 15(10):983-989. PubMed ID: 30173543
[TBL] [Abstract][Full Text] [Related]
14. A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis.
Turner R; Weaver S; Caserta F; Brown MB
Int J Pharm Compd; 2016; 20(1):71-80. PubMed ID: 27125057
[TBL] [Abstract][Full Text] [Related]
15. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
Kircik LH
J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
[TBL] [Abstract][Full Text] [Related]
16. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
[TBL] [Abstract][Full Text] [Related]
17. Novel Drug Delivery Strategies for the Treatment of Onychomycosis.
Dhamoon RK; Popli H; Gupta M
Pharm Nanotechnol; 2019; 7(1):24-38. PubMed ID: 31092174
[TBL] [Abstract][Full Text] [Related]
18. Efinaconazole 10% and Tavaborole 5% Penetrate Across Poly-ureaurethane 16%: Results of In Vitro Release Testing and Clinical Implications of Onychodystrophy in Onychomycosis.
Adigun CG; Vlahovic TC; McClellan MB; Thakker KD; Klein RR; Elstrom TA; Ward DB
J Drugs Dermatol; 2016 Sep; 15(9):1116-20. PubMed ID: 27602975
[TBL] [Abstract][Full Text] [Related]
19. Bacterial nanocellulose patches as a carrier for hydrating formulations to improve the topical treatment of nail diseases.
Bellmann T; Luber R; Kischio L; Karl B; Pötzinger Y; Beekmann U; Kralisch D; Wiegand C; Fischer D
Int J Pharm; 2022 Nov; 628():122267. PubMed ID: 36209980
[TBL] [Abstract][Full Text] [Related]
20. Recent progress on the topical therapy of onychomycosis.
Alley MR; Baker SJ; Beutner KR; Plattner J
Expert Opin Investig Drugs; 2007 Feb; 16(2):157-67. PubMed ID: 17243936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]